Tokyo - Delayed Quote JPY

BrightPath Biotherapeutics Co., Ltd. (4594.T)

42.00
+1.00
+(2.44%)
At close: 3:30:00 PM GMT+9
Currency in JPY All numbers in thousands
Download
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Revenue
72
72
5,280
15,408
2,504
Cost of Revenue
18
18
1,895
3,317
1,145
Gross Profit
54
54
3,384
12,091
1,358
Operating Expense
1,155,133
1,155,133
1,470,443
1,488,124
1,734,161
Operating Income
-1,155,079
-1,155,079
-1,467,059
-1,476,033
-1,732,803
Net Non Operating Interest Income Expense
-1,387
-1,387
-2,135
-2,532
-9,064
Pretax Income
-1,166,182
-1,166,182
-1,483,733
-1,481,772
-1,717,214
Tax Provision
1,900
1,900
1,900
2,420
2,420
Net Income Common Stockholders
-1,168,082
-1,168,082
-1,485,633
-1,484,192
-1,719,634
Diluted NI Available to Com Stockholders
-1,168,082
-1,168,082
-1,485,633
-1,484,192
-1,719,634
Basic EPS
-18.21
-18.21
-24.90
-28.55
-36.14
Diluted EPS
-18.21
-18.21
-24.90
-28.55
-36.14
Basic Average Shares
64,162.27
64,162.27
59,660.27
51,993.13
47,581.92
Diluted Average Shares
70,741.30
64,162.27
59,660.27
51,993.13
47,581.92
Total Operating Income as Reported
-1,155,078
-1,155,078
-1,467,059
-1,476,033
-1,732,802
Total Expenses
1,155,151
1,155,151
1,472,338
1,491,441
1,735,306
Net Income from Continuing & Discontinued Operation
-1,168,082
-1,168,082
-1,485,633
-1,484,192
-1,719,634
Normalized Income
-1,162,512.46
-1,162,512.46
-1,477,985.26
-1,484,325.63
-1,734,496.58
Interest Income
12
12
20
27
35
Interest Expense
0
0
61
362
0
Net Interest Income
-1,387
-1,387
-2,135
-2,532
-9,064
EBIT
-1,166,182
-1,166,182
-1,483,672
-1,481,410
-1,717,214
EBITDA
-1,165,787
-1,165,787
-1,466,953
-1,446,287
-1,650,526
Reconciled Cost of Revenue
18
18
1,895
3,317
1,145
Reconciled Depreciation
395
395
16,719
35,123
66,688
Net Income from Continuing Operation Net Minority Interest
-1,168,082
-1,168,082
-1,485,633
-1,484,192
-1,719,634
Total Unusual Items Excluding Goodwill
-7,252
-7,252
-9,958
174
21,422
Total Unusual Items
-7,252
-7,252
-9,958
174
21,422
Normalized EBITDA
-1,158,535
-1,158,535
-1,456,995
-1,446,461
-1,671,948
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-1,682.46
-1,682.46
-2,310.26
40.37
6,559.42
3/31/2021 - 10/22/2015

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

DRMA Dermata Therapeutics, Inc.
0.7766
-1.17%
 
ACLX Arcellx, Inc.
57.96
-0.50%
 
ADMA ADMA Biologics, Inc.
19.19
-3.47%
 
NVAX Novavax, Inc.
6.02
-2.75%